Therapeutic Indications

Ceftazidime is indicated for:

Broncho-pulmonary infections in cystic fibrosis

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily

Bone and joint infections, complicated skin and soft tissue infections

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily

Chronic purulent otitis media, malignant otitis externa

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily

Complicated intra-abdominal infections

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily

Peritonitis associated with dialysis in patients on CAPD

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily

Febrile neutropenia

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily

Nosocomial pneumonia

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-200 mg/kg continuous infusion daily

Complicated urinary tract infections

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily

Bacterial meningitis

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily

Bacterial infections

Irrespective of gender only Newborns (0 - 40 days old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 25-60 mg/kg in 2 divided doses daily

Broncho-pulmonary infections in cystic fibrosis

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily

Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Bone and joint infections, complicated skin and soft tissue infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 3-6 g in 3 divided doses daily

Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Chronic purulent otitis media, malignant otitis externa

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 3-6 g in 3 divided doses daily

Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily

Complicated intra-abdominal infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 3-6 g in 3 divided doses daily

Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Peri-operative prophylaxis for transuretheral resection of prostate (TURP)

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 1 g once

Peritonitis associated with dialysis in patients on CAPD

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 3-6 g in 3 divided doses daily

Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Febrile neutropenia

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 6 g in 3 divided doses daily

Treatment 2: Intramuscular - 6 g in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Nosocomial pneumonia

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 6 g in 3 divided doses daily

Treatment 2: Intramuscular - 6 g in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Complicated urinary tract infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 2-6 g in 2-3 divided doses daily

Treatment 2: Intramuscular - 2-6 g in 2-3 divided doses daily

Bacterial meningitis

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 6 g in 3 divided doses daily

Treatment 2: Intramuscular - 6 g in 3 divided doses daily

Treatment 3: Intravenous - 4-6 g continuous infusion daily

Contraindications

Active ingredient Ceftazidime is contraindicated in the following cases:

Hypersensitivity to cephalosporins

No gender/age discrimination

Hypersensitivity to the active substance, to any other cephalosporin.